Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.
Kelley RK, Nimeiri HS, Munster PN, Vergo MT, Huang Y, Li CM, Hwang J, Mulcahy MF, Yeh BM, Kuhn P, Luttgen MS, Grabowsky JA, Stucky-Marshall L, Korn WM, Ko AH, Bergsland EK, Benson AB 3rd, Venook AP.
Kelley RK, et al. Among authors: mulcahy mf.
Ann Oncol. 2013 Jul;24(7):1900-1907. doi: 10.1093/annonc/mdt109. Epub 2013 Mar 21.
Ann Oncol. 2013.
PMID: 23519998
Free PMC article.
Clinical Trial.